Research & Literature

Effectiveness of an Adapted Diabetes Prevention Program Lifestyle Intervention in Older and Younger Adults.

Brokaw SM, Carpenedo D, Campbell P, et al.

Journal of the American Geriatrics Society 2015; (63(6)):1067-74 doi:10.1111/jgs.13428.

Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.

The lancet. Diabetes & endocrinology 2015; (3(11)):866-75.

A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes.

Stefan N, Staiger H, Wagner R, et al.

Diabetologia 2015; (58(12)):2877-84 doi:10.1007/s00125-015-3760-z.

Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes.

Dujic T, Causevic A, Bego T, et al.

Diabetic medicine : a journal of the British Diabetic Association 2016; (33(4)):511-4 doi:10.1111/dme.13040.

Prediabetes and Risk of Glomerular Hyperfiltration and Albuminuria in the General Nondiabetic Population: A Prospective Cohort Study.

Melsom T, Schei J, Stefansson VT, et al.

American journal of kidney diseases : the official journal of the National Kidney Foundation 2016; (67(6)):841-50.

Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance.

Aoyama-Sasabe S, Fukushima M, Xin X, et al.

Journal of diabetes research 2016; (2016()):1298601 doi:10.1155/2016/1298601.

Prediabetes Phenotype Influences Improvements in Glucose Homeostasis with Resistance Training.

Eikenberg JD, Savla J, Marinik EL, et al.

PloS one 2016; (11(2)):e0148009 doi:10.1371/journal.pone.0148009.

Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study.

Aroda VR, Edelstein SL, Goldberg RB, et al.

The Journal of clinical endocrinology and metabolism 2016; (101(4)):1754-61 doi:10.1210/jc.2015-3754.

Gender-related affecting factors of prediabetes on its 10-year outcome.

Song X, Qiu M, Zhang X, et al.

BMJ open diabetes research & care 2016; (4(1)):e000169 doi:10.1136/bmjdrc-2015-000169.

The Stepwise Approach to Diabetes Prevention: Results From the D-CLIP Randomized Controlled Trial.

Weber MB, Ranjani H, Staimez LR, et al.

Diabetes care 2016; (39(10)):1760-7 doi:10.2337/dc16-1241.

Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis.

Huang Y, Cai X, Mai W, et al.

BMJ (Clinical research ed.) 2016; (355()):i5953 doi:10.1136/bmj.i5953.

Incidence and predictors of type 2 diabetes among Koreans: A 12-year follow up of the Korean Genome and Epidemiology Study.

Han SJ, Kim HJ, Kim DJ, et al.

Diabetes research and clinical practice 2017; (123()):173-180 doi:10.1016/j.diabres.2016.10.004.

Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study.

Connelly PJ, Lonergan M, Soto-Pedre E, et al.

Diabetes, obesity & metabolism 2017; (19(11)):1579-1586 doi:10.1111/dom.12978.

A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC's National Diabetes Prevention Program.

Ely EK, Gruss SM, Luman ET, et al.

Diabetes care 2017; (40(10)):1331-1341 doi:10.2337/dc16-2099.

Weight loss in the prevention and treatment of diabetes.

Delahanty LM

Preventive medicine 2017; (104()):120-123 doi:10.1016/j.ypmed.2017.07.022.

Risk of Cardiovascular Disease and Death in Individuals With Prediabetes Defined by Different Criteria: The Whitehall II Study.

Vistisen D, Witte DR, Brunner EJ, et al.

Diabetes care 2018; (41(4)):899-906 doi:10.2337/dc17-2530.

Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014.

Ali MK, Bullard KM, Saydah S, et al.

The lancet. Diabetes & endocrinology 2018; (6(5)):392-403 doi:10.1016/S2213-8587(18)30027-5.

Diabetes and obesity are the main metabolic drivers of peripheral neuropathy.

Callaghan BC, Gao L, Li Y, et al.

Annals of clinical and translational neurology 2018; (5(4)):397-405 doi:10.1002/acn3.531.

Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.

Franch-Nadal J, Caballeria L, Mata-Cases M, et al.

PloS one 2018; (13(6)):e0198327 doi:10.1371/journal.pone.0198327.

Long-term Outcomes of Lifestyle Intervention to Prevent Diabetes in American Indian and Alaska Native Communities: The Special Diabetes Program for Indians Diabetes Prevention Program.

Jiang L, Johnson A, Pratte K, et al.

Diabetes care 2018; (41(7)):1462-1470 doi:10.2337/dc17-2685.

Prevalence of Abnormal Glucose Regulation according to Different Diagnostic Criteria in Ischaemic Stroke without a History of Diabetes.

Zhang X, Shi Q, Zheng H, et al.

BioMed research international 2018; (2018()):8358724 doi:10.1155/2018/8358724.

Presessions to the National Diabetes Prevention Program May be a Promising Strategy to Improve Attendance and Weight Loss Outcomes.

Ritchie ND, Kaufmann PG, Gritz RM, et al.

American journal of health promotion : AJHP 2019; (33(2)):289-292 doi:10.1177/0890117118786195.

Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis.

Glechner A, Keuchel L, Affengruber L, et al.

Primary care diabetes 2018; (12(5)):393-408 doi:10.1016/j.pcd.2018.07.003.

Dietary Interventions for the Prevention of Type 2 Diabetes in High-Risk Groups: Current State of Evidence and Future Research Needs.

Guess ND

Nutrients 2018; (10(9)) doi:10.3390/nu10091245.

Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Adiposity.

Cardenas A, Hauser R, Gold DR, et al.

JAMA network open 2018; (1(4)):e181493 doi:10.1001/jamanetworkopen.2018.1493.

Differential role of insulin resistance and β-cell function in the development of prediabetes and diabetes in middle-aged and elderly Chinese population.

Cai X, Xia L, Pan Y, et al.

Diabetology & metabolic syndrome 2019; (11()):24 doi:10.1186/s13098-019-0418-x.

Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.

Diabetes care 2019; (42(4)):601-608 doi:10.2337/dc18-1970.

A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease.

Chen LW, Huang PR, Chien CH, et al.

Journal of the Formosan Medical Association = Taiwan yi zhi 2020; (119(1 Pt 1)):173-181 doi:10.1016/j.jfma.2019.03.016.

Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: The IT-DIAB study.

Wargny M, Smati S, Pichelin M, et al.

PloS one 2019; (14(8)):e0221524 doi:10.1371/journal.pone.0221524.

Prediabetes and Risk for Cardiovascular Disease by Hypertension Status in Black Adults: The Jackson Heart Study.

Hubbard D, Colantonio LD, Tanner RM, et al.

Diabetes care 2019; (42(12)):2322-2329 doi:10.2337/dc19-1074.

Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes.

Kim J, Ahn CW, Fang S, et al.

Medicine 2019; (98(46)):e17918 doi:10.1097/MD.0000000000017918.

Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.

Andes LJ, Cheng YJ, Rolka DB, et al.

JAMA pediatrics 2020; (174(2)):e194498 doi:10.1001/jamapediatrics.2019.4498.

Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank.

Welsh C, Welsh P, Celis-Morales CA, et al.

Diabetes care 2020; (43(2)):440-445 doi:10.2337/dc19-1683.

A position statement on screening and management of prediabetes in adults in primary care in Australia.

Bell K, Shaw JE, Maple-Brown L, et al.

Diabetes research and clinical practice 2020; (164()):108188 doi:10.1016/j.diabres.2020.108188.

A Unique Case of Metformin-associated Severe Lactic Acidosis Without Preexisting Renal Disease: Perspectives on Prolonged Dialysis and Education for Prevention.

Abad K, Kien C, Ganta K

Cureus 2020; (12(4)):e7564 doi:10.7759/cureus.7564.

Lifestyle and Progression to Type 2 Diabetes in a Cohort of Workers with Prediabetes.

Bennasar-Veny M, Fresneda S, López-González A, et al.

Nutrients 2020; (12(5)) doi:10.3390/nu12051538.

Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) Study: design of lifestyle intervention.

Dagogo-Jack S, Brewer AA, Owei I, et al.

BMJ open diabetes research & care 2020; (8(1)) doi:10.1136/bmjdrc-2019-000899.

Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis.

Cai X, Zhang Y, Li M, et al.

BMJ (Clinical research ed.) 2020; (370()):m2297 doi:10.1136/bmj.m2297.

Lifestyle Intervention With or Without Lay Volunteers to Prevent Type 2 Diabetes in People With Impaired Fasting Glucose and/or Nondiabetic Hyperglycemia: A Randomized Clinical Trial.

Sampson M, Clark A, Bachmann M, et al.

JAMA internal medicine 2021; (181(2)):168-178 doi:10.1001/jamainternmed.2020.5938.

The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review.

Eleftheriadou A, Williams S, Nevitt S, et al.

Diabetologia 2021; (64(2)):288-303 doi:10.1007/s00125-020-05316-z.

Comparing the effects of 12 months aerobic exercise and resistance training on glucose metabolism among prediabetes phenotype: A explorative randomized controlled trial.

Liu L, Ma X, Xu H, et al.

Primary care diabetes 2021; (15(2)):340-346 doi:10.1016/j.pcd.2020.11.003.

Once-Weekly Semaglutide in Adults with Overweight or Obesity.

Wilding JPH, Batterham RL, Calanna S, et al.

The New England journal of medicine 2021; (384(11)):989-1002 doi:10.1056/NEJMoa2032183.

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.

Rubino D, Abrahamsson N, Davies M, et al.

JAMA 2021; (325(14)):1414-1425 doi:10.1001/jama.2021.3224.

Changes in β-Cell Function in Offspring of Type-2 Diabetic Patients, as per Fasting and Two-Hour Plasma Glucose Levels.

Praveen EP, Chouhan S, Sahoo J, et al.

Cureus 2021; (13(5)):e15056 doi:10.7759/cureus.15056.

Profiles of Glucose Metabolism in Different Prediabetes Phenotypes, Classified by Fasting Glycemia, 2-Hour OGTT, Glycated Hemoglobin, and 1-Hour OGTT: An IMI DIRECT Study.

Tura A, Grespan E, Göbl CS, et al.

Diabetes 2021; (70(9)):2092-2106 doi:10.2337/db21-0227.

The PERSonalized Glucose Optimization Through Nutritional Intervention (PERSON) Study: Rationale, Design and Preliminary Screening Results.

Gijbels A, Trouwborst I, Jardon KM, et al.

Frontiers in nutrition 2021; (8()):694568 doi:10.3389/fnut.2021.694568.

Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement.

, Davidson KW, Barry MJ, et al.

JAMA 2021; (326(8)):736-743 doi:10.1001/jama.2021.12531.

Fatty liver index and progression to type 2 diabetes: a 5-year longitudinal study in Spanish workers with pre-diabetes.

Busquets-Cortés C, Bennasar-Veny M, López-González AA, et al.

BMJ open 2021; (11(8)):e045498 doi:10.1136/bmjopen-2020-045498.

A Narrative Review of Human Clinical Trials on the Impact of Phenolic-Rich Plant Extracts on Prediabetes and Its Subgroups.

Lim WXJ, Gammon CS, von Hurst P, et al.

Nutrients 2021; (13(11)) doi:10.3390/nu13113733.

Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes.

Liu Y, Li J, Wu Y, et al.

Frontiers in endocrinology 2022; (13()):835460 doi:10.3389/fendo.2022.835460.

The prevalence of retinopathy in prediabetes: A systematic review.

Kirthi V, Nderitu P, Alam U, et al.

Survey of ophthalmology 2022; (67(5)):1332-1345 doi:10.1016/j.survophthal.2022.04.002.

Does the Effect of a 3-Year Lifestyle Intervention on Body Weight and Cardiometabolic Health Differ by Prediabetes Metabolic Phenotype? A Post Hoc Analysis of the PREVIEW Study.

Zhu R, Jalo E, Silvestre MP, et al.

Diabetes care 2022; (45(11)):2698-2708 doi:10.2337/dc22-0549.

Use and Impact of Type 2 Diabetes Prevention Interventions.

Campione JR, Ritchie ND, Fishbein HA, et al.

American journal of preventive medicine 2022; (63(4)):603-610 doi:10.1016/j.amepre.2022.04.002.

Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program.

Perreault L, Davies M, Frias JP, et al.

Diabetes care 2022; (45(10)):2396-2405 doi:10.2337/dc21-1785.

The Diabetes Prevention Gap And Opportunities To Increase Participation In Effective Interventions.

Alva ML, Chakkalakal RJ, Moin T, Galaviz KI

Health affairs (Project Hope) 2022; (41(7)):971-979 doi:10.1377/hlthaff.2022.00259.

Uncertainty and certainty: perceptions and experiences of prediabetes in New Zealand primary care – a qualitative study.

McKinlay E, Hilder J, Hood F, et al.

Journal of primary health care 2022; (14(2)):138-145 doi:10.1071/HC21066.

Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes.

Neves JS, Newman C, Bostrom JA, et al.

Diabetes research and clinical practice 2022; (190()):109980 doi:10.1016/j.diabres.2022.109980.

The use of metformin for type 2 diabetes prevention: Observational multicenter study from Saudi Arabia.

Alfayez OM, Alsallum AA, Aljabri AF, et al.

Frontiers in public health 2022; (10()):989072 doi:10.3389/fpubh.2022.989072.

Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?

Alizadeh Z, Baradaran HR, Kohansal K, et al.

Frontiers in endocrinology 2022; (13()):1041808 doi:10.3389/fendo.2022.1041808.

Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence.

Muzurović EM, Volčanšek Š, Tomšić KZ, et al.

Journal of cardiovascular pharmacology and therapeutics 2022; (27()):10742484221146371 doi:10.1177/10742484221146371.

Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis.

Tan HC, Dampil OA, Marquez MM

Journal of the ASEAN Federation of Endocrine Societies 2022; (37(2)):65-72 doi:10.15605/jafes.037.02.14.

Perspectives on Prediabetes and Aging.

Al-Sofiani ME, Asiri A, Alajmi S, Alkeridy W

Endocrinology and metabolism clinics of North America 2023; (52(2)):377-388 doi:10.1016/j.ecl.2022.10.011.

Diagnosis and Management of Prediabetes: A Review.

Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S

JAMA 2023; (329(14)):1206-1216 doi:10.1001/jama.2023.4063.

MAFLD and glomerular hyperfiltration in subjects with prediabetes, visceral obesity and "preserved" kidney function: A cross-sectional study.

Parvanova A, Abbate M, Yañez AM, et al.

Diabetes research and clinical practice 2023; (201()):110729 doi:10.1016/j.diabres.2023.110729.

Neuropathy in prediabetes.

Ziegler D, Herder C, Papanas N

Diabetes/metabolism research and reviews 2023; (39(8)):e3693 doi:10.1002/dmrr.3693.

Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes.

Yamagata F, Ogata R, Koda Y, et al.

Journal of diabetes investigation 2024; (15(2)):177-185 doi:10.1111/jdi.14092.

Delivering the National Diabetes Prevention Program: Assessment of Outcomes in In-Person and Virtual Organizations.

Ely EK, Ng BP, Cannon MJ

Journal of diabetes research 2023; (2023()):8894593 doi:10.1155/2023/8894593.

Prevalence of Retinopathy in Prediabetic Populations: A Systematic Review and Meta-Analysis.

Sune MP, Sune M, Sune P, Dhok A

Cureus 2023; (15(11)):e49602 doi:10.7759/cureus.49602.

Natural History of Type 2 Diabetes in Indians: Time to Progression.

Narayan KMV, Kondal D, Chang HH, et al.

Diabetes care 2024; (47(5)):858-863 doi:10.2337/dc23-1514.

Exercise training modalities in prediabetes: a systematic review and network meta-analysis.

Zhang H, Guo Y, Hua G, et al.

Frontiers in endocrinology 2024; (15()):1308959 doi:10.3389/fendo.2024.1308959.

Metformin-associated lactic acidosis: A mini review of pathophysiology, diagnosis and management in critically ill patients.

See KC

World journal of diabetes 2024; (15(6)):1178-1186 doi:10.4239/wjd.v15.i6.1178.

Optimizing metformin therapy in practice: Tailoring therapy in specific patient groups to improve tolerability, efficacy and outcomes.

Silverii GA

Diabetes, obesity & metabolism 2024; (26 Suppl 3()):42-54 doi:10.1111/dom.15749.

Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes.

Rooney MR, Wallace AS, Echouffo Tcheugui JB, et al.

Diabetologia 2025; (68(2)):357-366 doi:10.1007/s00125-024-06315-0.

Prevalence and factors linked to renal involvement in prediabetes patients across Europe in the ePREDICE trial.

Mas-Fontao S, Civantos E, Boukichou N, et al.

Scientific reports 2024; (14(1)):30336 doi:10.1038/s41598-024-79842-w.

Differential effect of nonpharmacological interventions according to prediabetes phenotype: Systematic review and meta-analysis of randomized clinical trials.

Zila-Velasque JP, Carrillo-Larco RM, Bernabe-Ortiz A

Diabetic medicine : a journal of the British Diabetic Association 2025; (42(5)):e15511 doi:10.1111/dme.15511.

Navigating CDC recognition for the National DPP in socially vulnerable communities: barriers, facilitators, and recommendations.

Formagini T, Rezwan A, Rodriguez D, et al.

Archives of public health = Archives belges de sante publique 2025; (83(1)):57 doi:10.1186/s13690-025-01532-4.

Insulin resistance in adipose tissue and fatty liver, but not fat mass, are involved in worsening glycaemic status: The Hiroshima study on glucose metabolism and cardiovascular diseases.

Sasaki N, Ueno Y, Ozono R, et al.

Diabetes, obesity & metabolism 2025; (27(6)):3025-3035 doi:10.1111/dom.16307.

Risk factors for progression to type 2 diabetes in prediabetes: a systematic review and meta-analysis.

Hu S, Ji W, Zhang Y, et al.

BMC public health 2025; (25(1)):1220 doi:10.1186/s12889-025-21404-4.

The Diabetes Prevention Program and Its Outcomes Study: NIDDK's Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact.

Crandall JP, Dabelea D, Knowler WC, et al.

Diabetes care 2025; (48(7)):1101-1111 doi:10.2337/dc25-0014.

Developing risk models for predicting incidence of diabetes and prediabetes in the first-degree relatives of Iranian patients with type 2 diabetes and comparison with the finnish diabetes risk score.

Shahraki PK, Feizi A, Aminorroaya S, et al.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 2025; (30()):17 doi:10.4103/jrms.jrms_139_23.

Altered GIP/GLP-1 Secretion Ratio is Associated With Impaired β Cell Function in Humans.

Di Giuseppe G, Gliozzo G, Ciccarelli G, et al.

The Journal of clinical endocrinology and metabolism 2025; (111(1)):e240-e246 doi:10.1210/clinem/dgaf210.

Is adherence to the alternate healthy eating index an effective approach for prediabetes reversion? A longitudinal follow-up.

Bahadoran Z, Mirmiran P, Azizi F

Clinical nutrition ESPEN 2025; (68()):548-556 doi:10.1016/j.clnesp.2025.05.046.

Exploring Patient Knowledge and Perspectives to Inform the Development of a Prediabetes Education Toolkit: A cross-Sectional Survey.

Basaka L, Palmisano C, Webber-Ritchey KJ

Journal of community health nursing 2025; (42(4)):257-268 doi:10.1080/07370016.2025.2517677.

Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: A Clinical Practice Guideline From the American College of Lifestyle Medicine.

Rosenfeld RM, Grega ML, Karlsen MC, et al.

American journal of lifestyle medicine 2025; (19(2 Suppl)):10S-131S doi:10.1177/15598276251325488.

Tirzepatide and cardiometabolic parameters in obesity: Summary of current evidence.

Sattar N, García-Pérez LE, Rodríguez A, et al.

Diabetes, obesity & metabolism 2025; (27(10)):5386-5392 doi:10.1111/dom.16549.

Dose-Dependent Efficacy and Safety of Tirzepatide for Weight Loss in Non-diabetic Adults With Obesity: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Kasagga A, Assefa AK, Amin MN, et al.

Cureus 2025; (17(6)):e85531 doi:10.7759/cureus.85531.

Tirzepatide Versus Semaglutide for Weight Loss in Overweight and Obese Adults: A Systematic Review and Meta-Analysis of Direct Comparative Studies.

Munawar N, Mahato A, Rawat A, et al.

Cureus 2025; (17(6)):e86080 doi:10.7759/cureus.86080.

Prediabetes transitions to normoglycaemia or type 2 diabetes and associated risk factors in the Obesity, Diabetes and Cardiovascular Disease Collaboration: an individual-level pooled analysis of 19 prospective cohort studies.

Davoodian N, Lotfaliany M, Huxley RR, et al.

The Lancet. Global health 2025; (13(9)):e1533-e1542 doi:10.1016/S2214-109X(25)00237-2.

A primary care guide to the screening and pharmacologic management of chronic kidney disease in people living with type 2 diabetes.

Wright EE, Cebrian A, Ngui D

Primary care diabetes 2025; (19(5)):411-421 doi:10.1016/j.pcd.2025.05.005.

Modified cut-off value of the urine albumin-to-creatinine ratio is helpful for identifying patients at high risk for chronic kidney disease in prediabetes.

Liu J, Yang L, Wu J, et al.

Acta diabetologica 2025; doi:10.1007/s00592-025-02518-y.

Effectiveness of an Incentives-Enhanced Stepped Care Intervention Program in Diabetes Prevention in a Multiethnic Asian Prediabetes Cohort: Results From the Pre-DICTED Randomized Controlled Trial.

Bee YM, Awasthi N, Gandhi M, et al.

Diabetes care 2025; (48(11)):1951-1959 doi:10.2337/dc25-1555.

Navigating Prediabetes in a Foreign Country: A Qualitative Study of Self-Management Experiences Among Chinese-Speaking Immigrants in Australia.

Zhang M, Coppell KJ, Lo J, Whitehead L

Journal of advanced nursing 2026; (82(6)):6332-6348 doi:10.1111/jan.70214.

Prediabetes and the risk of incident chronic kidney disease in adults: A systematic review and meta-analysis.

Fang S, Huang J, Chen Y

Biomolecules & biomedicine 2026; (26(8)):1290-1305 doi:10.17305/bb.2026.13524.

Should Prediabetes Be Classified as a Treatable Disease?

Winter WE, Jialal I

Journal of clinical medicine 2026; (15(2)) doi:10.3390/jcm15020710.

Baseline and 4-year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort.

Izarra A, Bermúdez-López M, Valdivielso JM, et al.

Diabetes, obesity & metabolism 2026; (28(5)):3777-3787 doi:10.1111/dom.70560.

Prediabetes in Transition: Insights from the Tehran Lipid and Glucose Study.

Bahadoran Z, Hosseinpanah F

International journal of endocrinology and metabolism 2025; (23(4)):e166455 doi:10.5812/ijem-166455.

Causes and consequences of discontinuation of GLP1RAs or tirzepatide.

Ceriello A, Prattichizzo F, Mastan Sheik Abdullah AR, et al.

Nature reviews. Endocrinology 2026; (22(9)):530-542 doi:10.1038/s41574-026-01258-5.